Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 146.90
-4.10 (-2.72%)
Apr 20, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 135.32 billion as of April 20, 2026. Its market cap has increased by 129.29% in one year.
Market Cap
135.32B
Enterprise Value
130.07B
Revenue
3.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
146.90
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 135.32B, an increase of 629.70%. That is a compound annual growth rate of 39.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 135.32B | 30.00% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.22B |
| Innovent Biologics | 158.77B |
| WuXi Biologics | 147.80B |
| Sichuan Kelun-Biotech Biopharmaceutical | 121.26B |
| Sino Biopharmaceutical | 107.21B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.19B |